IOCB spin-off company DIANA Biotechnologies, s.r.o. was founded with the significant venture capital funding from the BPD Partners group in order to deliver DIANA products to the market. The company is based in its own research facilities in Vestec near Prague. The company was granted an exclusive license to develop commercial applications based on the DIANA and … Read more
Václav Navrátil’s team has been awarded the prestigious Werner von Siemens Award for 2017 for the development of the DIANA technology. This prize, sponsored by Siemens, is awarded each year to the best innovation project in the Czech Republic.
We are presenting DIANA at BioFIT event in Strasburg 28th-29th November 2017. Meet us there to learn about DIANA’s potential and discuss partnership opportunities.
We are presenting DIANA at Bio-Europe in Berlin 6th-8th November 2017. Meet us there to learn about DIANA’s potential and discuss partnership opportunities.
Our first research paper describing DIANA assay and outlining its application potential has been published in Nucleic Acids Research. Navratil et al. (2017): DIANA for sensitive and selective enzyme detection and inhibitor screening
We have applied for an international patent protection of DIANA assay technology and its applications in drug discovery and diagnostics.